Beta Bionics is one of the most exciting IPO stories of 2025

Beta Bionics (BBNX) is one of the most promising IPO stories of this year in my opinion, which is now offering a good risk-reward ratio after a strong Q2. With the iLet insulin pump system, there is the only approved adaptive closed-loop algorithm for insulin pump management. Type 1 diabetics can automate insulin delivery simply by entering their body weight. The number of users has now tripled to 24,085. 71% of new customers are switching from multiple daily insulin injections (MDI) to insulin pumps. Of the 1.9 million Type 1 diabetics...